DB17994Approved
Influenza A Virus A/Victoria/4897/2022 IVR-238 (H1N1) antigen (formaldehyde inactivated) is a component of an inactivated influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that helps to protect against infection from influenza viruses.
- First approval
- United States, 2023 · European Union, 2025
- Brand names
Resolves to
Compound
What you can answer from here — as of September 01, 2026
Which companies are running trials of Influenza A Virus A/Victoria/4897/2022 IVR-238 (H1N1) antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account